Literature DB >> 11158100

Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens.

P Apfalter1, F Blasi, J Boman, C A Gaydos, M Kundi, M Maass, A Makristathis, A Meijer, R Nadrchal, K Persson, M L Rotter, C Y Tong, G Stanek, A M Hirschl.   

Abstract

The reported rate of detection of Chlamydia pneumoniae DNA within atherosclerotic lesions by PCR varies between 0 and 100%. In this study, identical sets of coded experimental atheroma samples (n = 15) and spiked controls (n = 5) were analyzed by 16 test methods in nine centers by means of PCR. The positive controls were correctly identified to levels of 1, 0.1, and 0.01 inclusion bodies of C. pneumoniae/ml of tissue homogenate by 16 (100%), 11 (69%), and 3 (19%) of the test methods, respectively. Three out of 16 negative controls (19%) were rated positive. Positivity rates for atheroma samples varied between 0 and 60% for the different test methods, with the maximum concordant result for positivity being only 25% for one carotid artery sample. There was no consistent pattern of positive results among the various laboratories, and there was no correlation between the detection rates and the sensitivity of the assay used.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158100      PMCID: PMC87769          DOI: 10.1128/JCM.39.2.519-524.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications.

Authors:  G Ong; B J Thomas; A O Mansfield; B R Davidson; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.

Authors:  C Y Tong; M Sillis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

4.  Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes.

Authors:  G Madico; T C Quinn; J Boman; C A Gaydos
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 5.  Chlamydia pneumoniae (TWAR).

Authors:  C C Kuo; L A Jackson; L A Campbell; J T Grayston
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Detection of Chlamydia pneumoniae by polymerase chain reaction.

Authors:  L A Campbell; M Perez Melgosa; D J Hamilton; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

7.  Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene.

Authors:  C A Gaydos; T C Quinn; J J Eiden
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

8.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

9.  Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population.

Authors:  C A Gaydos; C L Fowler; V J Gill; J J Eiden; T C Quinn
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

10.  Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.

Authors:  S M Weiss; P M Roblin; C A Gaydos; P Cummings; D L Patton; N Schulhoff; J Shani; R Frankel; K Penney; T C Quinn; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

View more
  33 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 2.  PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids.

Authors:  Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

3.  Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR.

Authors:  U Reischl; N Lehn; U Simnacher; R Marre; A Essig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-24       Impact factor: 3.267

4.  Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories.

Authors:  Max Chernesky; Marek Smieja; Julius Schachter; James Summersgill; Laura Schindler; Natalie Solomon; Karen Campbell; LeeAnn Campbell; Alison Cappuccio; Charlotte Gaydos; Sylvia Chong; Jeanne Moncada; Jack Phillips; Dan Jang; Billie Jo Wood; Astrid Petrich; Margaret Hammerschlag; Mike Cerney; James Mahony
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

5.  Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.

Authors:  Petra Apfalter; Wolfgang Barousch; Marion Nehr; Athanasios Makristathis; Birgit Willinger; Manfred Rotter; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Detection and differentiation of chlamydiae by fluorescence in situ hybridization.

Authors:  Sven Poppert; Andreas Essig; Reinhard Marre; Michael Wagner; Matthias Horn
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

7.  Real-time PCR for Chlamydia pneumoniae utilizing the Roche Lightcycler and a 16S rRNA gene target.

Authors:  Justin Hardick; Nancy Maldeis; Mellisa Theodore; Billie Jo Wood; Samuel Yang; Shin Lin; Thomas Quinn; Charlotte Gaydos
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 8.  Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.

Authors:  Margareta M Ieven; Vicky Y Hoymans
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 9.  In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?

Authors:  Petra Apfalter; Udo Reischl; Margaret R Hammerschlag
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

10.  Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial.

Authors:  Hans F Berg; Boulos Maraha; Anneke van der Zee; Siska K Gielis; Paul J M Roholl; Gert-Jan Scheffer; Marcel F Peeters; Jan A J W Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.